Leukemia - Table of Contents alert Volume 31 Issue 2

If you are unable to see the message below, click here to view.

Advertisement The Bass Center for Childhood Cancer & Blood Diseases at Stanford Children's Health is a leading center for the treatment of leukemia and lymphomas in children. Nationally ranked and part of NCI-designated Stanford Cancer Institute, we're committed to outstanding clinical care, groundbreaking research and state-of-the-art treatment for children with cancer.  Learn more at basscenter.stanfordchildrens.org  TABLE OF CONTENTS Volume 31, Issue 2 (February 2017) In this issue Editorial Reviews Original Articles Letters To The Editor Correspondence Also new AOP Sign up for e-alerts Recommend to your library Web feed Follow on Twitter Subscribe Advertisement Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders. Explore the benefits of submitting your next research article. Editorial Top Acute myeloid leukemia therapy and the chosen people E Estey and R P Gale Leukemia 2017 31: 269-271; advance online publication, November 11, 2016; 10.1038/leu.2016.306 Full Text Reviews Top Isocitrate dehydrogenase mutations in myeloid malignancies OPEN B C Medeiros, A T Fathi, C D DiNardo, D A Pollyea, S M Chan and R Swords Leukemia 2017 31: 272-281; advance online publication, October 10, 2016; 10.1038/leu.2016.275 Abstract | Full Text Antigen receptor stereotypy in chronic lymphocytic leukemia K Stamatopoulos, A Agathangelidis, R Rosenquist and P Ghia Leukemia 2017 31: 282-291; advance online publication, November 4, 2016; 10.1038/leu.2016.322 Abstract | Full Text Original Articles Top ACUTE MYELOID LEUKEMIA Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia L Quotti Tubi, S Canovas Nunes, A Brancalion, E Doriguzzi Breatta, S Manni, E Mandato, F Zaffino, P Macaccaro, M Carrino, K Gianesin, L Trentin, G Binotto, R Zambello, G Semenzato, C Gurrieri and F Piazza Leukemia 2017 31: 292-300; advance online publication, August 1, 2016; 10.1038/leu.2016.209 Abstract | Full Text HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia M Kontro, A Kumar, M M Majumder, S Eldfors, A Parsons, T Pemovska, J Saarela, B Yadav, D Malani, Y Fløisand, M Höglund, K Remes, B T Gjertsen, O Kallioniemi, K Wennerberg, C A Heckman and K Porkka Leukemia 2017 31: 301-309; advance online publication, August 8, 2016; 10.1038/leu.2016.222 Abstract | Full Text A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia OPEN A K Burnett, N H Russell, R K Hills, J Kell, O J Nielsen, M Dennis, P Cahalin, C Pocock, S Ali, S Burns, S Freeman, D Milligan and R E Clark on behalf of the UK NCRI AML Study Group Leukemia 2017 31: 310-317; advance online publication, September 2, 2016; 10.1038/leu.2016.225 Abstract | Full Text A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials G Montalban-Bravo, X Huang, E Jabbour, G Borthakur, C D DiNardo, N Pemmaraju, J Cortes, S Verstovsek, T Kadia, N Daver, W Wierda, Y Alvarado, M Konopleva, F Ravandi, Z Estrov, N Jain, A Alfonso, M Brandt, T Sneed, H-C Chen, H Yang, C Bueso-Ramos, S Pierce, E Estey, Z Bohannan, H M Kantarjian and G Garcia-Manero Leukemia 2017 31: 318-324; advance online publication, October 31, 2016; 10.1038/leu.2016.303 Abstract | Full Text ACUTE LYMPHOBLASTIC LEUKEMIA Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol B O Wolthers, T L Frandsen, J Abrahamsson, B K Albertsen, L R Helt, M Heyman, Ó G Jónsson, L T Kõrgvee, B Lund, R A Raja, K K Rasmussen, M Taskinen, M Tulstrup, G E Vaitkevičienė, R Yadav, R Gupta and K Schmiegelow on behalf of the Nordic Society of Pediatric Hematology and Oncology (NOPHO) Leukemia 2017 31: 325-332; advance online publication, July 25, 2016; 10.1038/leu.2016.203 Abstract | Full Text Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy C-H Pui, D Pei, S C Raimondi, E Coustan-Smith, S Jeha, C Cheng, W P Bowman, J T Sandlund, R C Ribeiro, J E Rubnitz, H Inaba, T A Gruber, W H Leung, J J Yang, J R Downing, W E Evans, M V Relling and D Campana Leukemia 2017 31: 333-339; advance online publication, August 18, 2016; 10.1038/leu.2016.234 Abstract | Full Text CHRONIC LYMPHOCYTIC LEUKEMIA Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia L M Saleh, W Wang, S E M Herman, N S Saba, V Anastas, E Barber, M Corrigan-Cummins, M Farooqui, C Sun, S M Sarasua, Z Zhao, N K Abousamra, O Elbaz, H A Abdelghaffar, A Wiestner and K R Calvo Leukemia 2017 31: 340-349; advance online publication, June 24, 2016; 10.1038/leu.2016.181 Abstract | Full Text Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression J Boysen, M Nelson, G Magzoub, G P Maiti, S Sinha, M Goswami, S K Vesely, T D Shanafelt, N E Kay and A K Ghosh Leukemia 2017 31: 350-360; advance online publication, August 2, 2016; 10.1038/leu.2016.217 Abstract | Full Text LYMPHOMA Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma F Linke, M Harenberg, M M Nietert, S Zaunig, F von Bonin, A Arlt, M Szczepanowski, H A Weich, S Lutz, C Dullin, P Janovská, M Krafčíková, L Trantírek, P Ovesná, W Klapper, T Beissbarth, F Alves, V Bryja, L Trümper, J Wilting and D Kube Leukemia 2017 31: 361-372; advance online publication, August 18, 2016; 10.1038/leu.2016.232 Abstract | Full Text MULTIPLE MYELOMA, GAMMOPATHIES Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma OPEN G McNee, K L Eales, W Wei, D S Williams, A Barkhuizen, D B Bartlett, S Essex, S Anandram, A Filer, P A H Moss, G Pratt, S Basu, C C Davies and D A Tennant Leukemia 2017 31: 373-381; advance online publication, July 11, 2016; 10.1038/leu.2016.187 Abstract | Full Text Differentiation stage of myeloma plasma cells: biological and clinical significance B Paiva, N Puig, M T Cedena, B G de Jong, Y Ruiz, I Rapado, J Martinez-Lopez, L Cordon, D Alignani, J A Delgado, M C van Zelm, J J M Van Dongen, M Pascual, X Agirre, F Prosper, J I Martín-Subero, M-B Vidriales, N C Gutierrez, M T Hernandez, A Oriol, M A Echeveste, Y Gonzalez, S K Johnson, J Epstein, B Barlogie, G J Morgan, A Orfao, J Blade, M V Mateos, J J Lahuerta and J F San-Miguel on behalf of GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study groups Leukemia 2017 31: 382-392; advance online publication, August 1, 2016; 10.1038/leu.2016.211 Abstract | Full Text CHRONIC MYELOPROLIFERATIVE NEOPLASMS A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis OPEN S Verstovsek, M Talpaz, E Ritchie, M Wadleigh, O Odenike, C Jamieson, B Stein, T Uno and R A Mesa Leukemia 2017 31: 393-402; advance online publication, August 1, 2016; 10.1038/leu.2016.215 Abstract | Full Text STEM CELL BIOLOGY A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal Z Zhang, P Zhu, Y Zhou, Y Sheng, Y Hong, D Xiang, Z Qian, J Mosenson and W-S Wu Leukemia 2017 31: 403-413; advance online publication, July 25, 2016; 10.1038/leu.2016.201 Abstract | Full Text Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia Y Fang, Y Yang, C Hua, S Xu, M Zhou, H Guo, N Wang, X Zhao, L Huang, F Yu, H Cheng, M L Wang, L Meng, T Cheng, W Yuan, D Ma and J Zhou Leukemia 2017 31: 414-422; advance online publication, August 8, 2016; 10.1038/leu.2016.223 Abstract | Full Text The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion W Du, S Amarachintha, A Wilson and Q Pang Leukemia 2017 31: 423-433; advance online publication, August 29, 2016; 10.1038/leu.2016.242 Abstract | Full Text STEM CELL TRANSPLANTATION HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation W Herr, Y Eichinger, J Beshay, A Bloetz, S Vatter, C Mirbeth, E Distler, U F Hartwig and S Thomas Leukemia 2017 31: 434-445; advance online publication, August 1, 2016; 10.1038/leu.2016.210 Abstract | Full Text MOLECULAR TARGETS FOR THERAPY Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1 OPEN A Abdelbaset-Ismail, S Borkowska-Rzeszotek, E Kubis, K Bujko, K Brzeźniakiewicz-Janus, L Bolkun, J Kloczko, M Moniuszko, G W Basak, W Wiktor-Jedrzejczak and M Z Ratajczak Leukemia 2017 31: 446-458; advance online publication, July 25, 2016; 10.1038/leu.2016.198 Abstract | Full Text IMMUNOTHERAPY An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia S P Koerner, M C André, J S Leibold, P C Kousis, A Kübler, M Pal, S P Haen, H-J Bühring, L Grosse-Hovest, G Jung and H R Salih Leukemia 2017 31: 459-469; advance online publication, July 20, 2016; 10.1038/leu.2016.194 Abstract | Full Text The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia M Qorraj, H Bruns, M Böttcher, L Weigand, D Saul, A Mackensen, R Jitschin and D Mougiakakos Leukemia 2017 31: 470-478; advance online publication, August 1, 2016; 10.1038/leu.2016.214 Abstract | Full Text TRANSCRIPTIONAL CONTROL AND SIGNAL TRANSDUCTION, CELL CYCLE Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors OPEN E Donato, O Croci, A Sabò, H Muller, M J Morelli, M Pelizzola and S Campaner Leukemia 2017 31: 479-490; advance online publication, June 24, 2016; 10.1038/leu.2016.182 Abstract | Full Text Letters To The Editor Top Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome M E Varney, K Choi, L Bolanos, S Christie, J Fang, L H Grimes, J P Maciejewski, J-I Inoue and D T Starczynowski Leukemia 2017 31: 491-495; advance online publication, October 3, 2016; 10.1038/leu.2016.276 Full Text The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms M O Holmström, M D Hjortsø, S M Ahmad, Ö Met, E Martinenaite, C Riley, P Straten, I M Svane, H C Hasselbalch and M H Andersen Leukemia 2017 31: 495-498; advance online publication, October 20, 2016; 10.1038/leu.2016.290 Full Text NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma E Pomari, G Basso, S Bresolin, M Pillon, E Carraro, E S d'Amore, G Viola, C Frasson, K Basso, P Bonvini and L Mussolin Leukemia 2017 31: 498-501; advance online publication, October 24, 2016; 10.1038/leu.2016.292 Full Text E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia I-K Park, W Blum, S D Baker and M A Caligiuri Leukemia 2017 31: 502-505; advance online publication, October 24, 2016; 10.1038/leu.2016.293 Full Text Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms V Visconte, B Przychodzen, Y Han, S T Nawrocki, S Thota, K R Kelly, B J Patel, C Hirsch, A S Advani, H E Carraway, M A Sekeres, J P Maciejewski and J S Carew Leukemia 2017 31: 505-510; advance online publication, October 24, 2016; 10.1038/leu.2016.295 Full Text Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial OPEN M Larrayoz, M J J Rose-Zerilli, L Kadalayil, H Parker, S Blakemore, J Forster, Z Davis, A J Steele, A Collins, M Else, D Catovsky, D G Oscier and J C Strefford Leukemia 2017 31: 510-514; advance online publication, October 26, 2016; 10.1038/leu.2016.298 Full Text A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3? OPEN E Troadec, S Dobbelstein, P Bertrand, N Faumont, F Trimoreau, M Touati, J Chauzeix, B Petit, D Bordessoule, J Feuillard, C Bastard and N Gachard Leukemia 2017 31: 514-517; advance online publication, October 31, 2016; 10.1038/leu.2016.304 Full Text Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499 M R Smith, F Hong, H Li, L I Gordon, R D Gascoyne, E M Paietta, R H Advani, A Forero-Torres, S J Horning and B S Kahl Leukemia 2017 31: 517-519; advance online publication, October 26, 2016; 10.1038/leu.2016.305 Full Text Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation G Berger, E van den Berg, B Sikkema-Raddatz, K M Abbott, R J Sinke, L B Bungener, A B Mulder and E Vellenga Leukemia 2017 31: 520-522; advance online publication, October 31, 2016; 10.1038/leu.2016.310 Full Text Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma W Piao, D Chau, L M Yue, Y-L Kwong and E Tse Leukemia 2017 31: 522-526; advance online publication, October 31, 2016; 10.1038/leu.2016.311 Full Text Correspondence Top Equivalence of BCSH and WHO diagnostic criteria for ET C N Harrison, M F McMullin, A R Green and A J Mead Leukemia 2017 31: 527-528; advance online publication, November 29, 2016; 10.1038/leu.2016.318 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.